TO MAKE ALL CHILDHOOD CANCERS UNIVERSALLY SURVIVABLE BY DELIVERING NEW TREATMENTS TO CLINICAL TRIALS THROUGH SCIENTIFIC DISCOVERY.
Executive compensation, broken down
Form 990 · Schedule J · 2 reported individuals · Filing year 2024
- Base
- $313k
- Bonus
- —
- Other
- —
- Benefits
- $6k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
Science Dir. officer (unspecified) | $313k | — | — | $6k | $346k $368k |
Executive Dir. officer (unspecified) | — | — | — | — | $78k $83k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 13 unpaid individuals.
Up 2%
from 2023
From $338k in 2023 to $346k in 2024.
Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Revenue and expenses over time
Childrens Cancer Therapy Development Institute reported revenue and expenses across 2 filing years.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.